StockTipsArenaBeta

BUY Anthem Biosciences Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities

BUYAnthem Biosciences Limited
Anthem Biosciences share price target & all analyst calls

bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: Swing (≤2wk)12 Aug 2026via NDTV Profit

Entry₹800Stated
Target₹990
Total upside +23.75% (call closed)
Stop lossNot given
Exit—No position was opened
ExpiredNA
Follow Sachin Janardan Sarvade for new calls(13% target hit, 87 closed calls)Get alertsWatch ANTHEM for new buy/sell callsGet alertsSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 25 Aug 2026
9 supporting1 neutral0 opposing
Supports the BUY call (9)

Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 target

NewsEt-Markets·21 Aug · 4d ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·17 Aug · 1w ago

Anthem Biosciences Share Price: லாபம் **₹591 கோடி** உயர்வு! பங்கு **2%** ஏற்றம்!

NewsGoogle News·3 Aug · 3w ago

(opens in new tab)

Anthem Biosciences Shares Gain 2% After Profit Rises to ₹591 Crore

NewsGoogle News·3 Aug · 3w ago

(opens in new tab)

Anthem Biosciences शेअरमध्ये तेजी! FY26 मध्ये नफा ₹591 कोटींवर

NewsGoogle News·3 Aug · 3w ago

(opens in new tab)
Neutral / worth noting (1)

Anthem Biosciences Share: दमदार FY26 नतीजे, पर Q1 FY27 में आई नरमी, निवेशक इन बातों पर रख रहे नज़र

NewsGoogle News·10 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anthem Biosciences

All analyst calls on Anthem Biosciences

More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities

Every call and its outcome